Purple Biotech (PPBT) Long-Term Investments (2019 - 2021)
Purple Biotech (PPBT) reported Long-Term Investments of $187000.0 for Q4 2021, down 90.65% quarter-over-quarter from $2.0 million in Q4 2019.
Purple Biotech (PPBT) Long-Term Investments (2019 - 2021) Analysis & Trends
Purple Biotech (PPBT) has 2 years of Long-Term Investments data on file, last reported at $187000.0 in Q4 2021.
- Long-Term Investments for Q4 2021 came in at $187000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $187000.0 (changed N/A YoY), and the FY2021 annual result was $187000.0, changed N/A from the prior year.
- Long-Term Investments declined to $187000.0 in Q4 2021 per PPBT's latest filing, from $2.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $2.0 million in Q4 2019 and troughed at $187000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 187,000.00 |
| Dec 31, 2019 | 2.00 Mn |